PharmaPEG-interferon-beta-1b (Mountain View Pharma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePharmaPEG-interferon-beta-1b (Mountain View Pharma)
Drug Alias NamePharmaPEG-interferon-beta (Mountain View Pharma)pegylated interferon-beta (Mountain View Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMountain View Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMountain View Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A